| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |